1-4 of 4
Samantha Hol
Close
Sort by
Journal Articles

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

Cordula Gründer, Suzanne van Dorp, Samantha Hol, Esther Drent, Trudy Straetemans, Sabine Heijhuurs, Kirsten Scholten, Wouter Scheper, Zsolt Sebestyen, Anton Martens, Roland Strong, Jürgen Kuball
Journal: Blood
Blood (2012) 120 (26): 5153–5162.
https://doi.org/10.1182/blood-2012-05-432427
Published: 2012
Includes: Supplemental data
Journal Articles

Improving Tumor Immunotherapy by Using Distinct Subpopulations of the γδT Cell Repertoire with High Anti-Tumor Reactivity.

Suzanne van Dorp, MD, Samantha Hol, Victoria Marcu-Malina, PhD, Nicole Thuss, Henk Lokhorst, MD, PhD, Juergen Kuball, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4504.
https://doi.org/10.1182/blood.V114.22.4504.4504
Published: 2009
Journal Articles

Generation of Graft-Versus-Leukemia (GVL)-Effector T Cells through Targeting of Leukemia-Associated HY Antigens Via TCR Transfer.

Roman Ivanov, MD, Samantha Hol, Tineke Aarts, Anton Hagenbeek, Saskia Ebeling
Journal: Blood
Blood (2004) 104 (11): 2117.
https://doi.org/10.1182/blood.V104.11.2117.2117
Published: 2004
Journal Articles

Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells

Peter Valk, Sandra Verbakel, Yolanda Vankan, Samantha Hol, Shanta Mancham, Rob Ploemacher, Angelique Mayen, Bob Löwenberg, Ruud Delwel
Journal: Blood
Blood (1997) 90 (4): 1448–1457.
https://doi.org/10.1182/blood.V90.4.1448
Published: 1997